Greg King

Greg King has over 35 years of experience in the medical device and technology industries. Greg began their career in 1982 as a Program Director at Xerox. In 1997, they joined dpiX as a Program Manager, where they were responsible for marketing, business development and program management. In 1999, they moved to Shape Technology as Vice President of Marketing. In 2000, they joined Optiva, Inc. as Executive Vice President of Operations and Marketing, where they were part of the leadership team to move the company from R&D into commercialization. In 2003, they joined XVD Corporation as Vice President of Operations and Marketing. In 2004, they were recruited to form an early stage company, Wostec, Inc., to commercialize a proprietary nano patterning fabrication technology. In 2010, they joined Carben Semicon/Ribtan, Inc. as CEO/President. In 2013, they became President/CEO of Fibralign Corporation, a Stanford University spin-out that produces advanced therapeutic biomedical devices. During their time at Fibralign Corporation, they launched the company's first product, BioBridge Collagen Matrix, for the treatment of secondary lymphedema. Greg also won the MedTech Innovator Award - Overall Winner, StartX Med, UCSF Rosenman Institute Innovator, and was part of the founding cohort of JLABS@SSF.

Greg King received their Bachelor's Degree in Electrical Engineering from Grove City College. Greg then went on to the University of Pittsburgh to study Electrical Engineering. After that, they pursued their MBA in Marketing/Operations/Finance from Penn State University.